review of literature on clinical pancreatology - The Pancreapedia

Hepatogastroenterology 2009; 56: 515-8.591. Yoon LS, Catalano OA, Fritz S, Ferrone CR, Hahn PF, Sahani DV. Another dimension inmagnetic resonance cholangiopancreatography: comparison <strong>of</strong> 2- and 3-dimensional magneticresonance cholangiopancreatography for the evaluation <strong>of</strong> intraductal papillary mucinous neoplasm <strong>of</strong>the pancreas. J Comput Assist Tomogr 2009; 33: 363-8.592. Ringold DA, Shr<strong>of</strong>f P, Sikka SK, Ylagan L, Jonnalagadda S, Early DS, Edmundowicz SA, Azar R.Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasiadiagnosed by EUS. Gastrointest Endosc 2009 Jun 23 [Epub ahead <strong>of</strong> print].593. Pala C, Serventi F, Scognamillo F, Attene F, Pisano IP, Cugia L, Meloni M, Trignano M. Cysticpancreatic tumor treated by distal spleno-pancreatectomy with occasional diagnosis <strong>of</strong> neuroendocrinetumor: case report. Ann Ital Chir 2008; 79: 451-6 (in Italian).594. Oh SJ, Lee SJ, Lee HY, Paik YH, Lee DK, Lee KS, Chung JB, Yu JS, Yoon DS. Extrapancreatictumors in intraductal papillary mucinous neoplasm <strong>of</strong> the pancreas. Korean J Gastroenterol 2009; 54:162-6 (in Korean).595. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.Treatment strategy for intraductal papillary mucinous neoplasm <strong>of</strong> the pancreas based on malignantpredictive factors. Arch Surg 2009; 144: 345-9.596. Gill KR, Pelaez-Luna M, Keaveny A, Woodward TA, Wallace MB, Chari ST, Smyrk TC,Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M,Farnell MB, Raimondo M. Branch duct intraductal papillary mucinous neoplasm <strong>of</strong> the pancreas insolid organ transplant recipients. Am J Gastroenterol 2009; 104: 1256-61.597. Nara S, Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. Clinical significance <strong>of</strong> frozensection analysis during resection <strong>of</strong> intraductal papillary mucinous neoplasm: should a positivepancreatic margin for adenoma or borderline lesion be resected additionally? J Am Coll Surg 2009;209: 614-21.598. Ishikawa T, Takeda K, Itoh M, Imaizumi T, Oguri K, Takahashi H, Kasuga H, Toriyama T, MatsuoS, Hirooka Y, Itoh A, Kawashima H, Kasugai T, Ohno E, Miyahara R, Ishigami M, Katano Y, OhmiyaN, Niwa Y, Goto H. Prevalence <strong>of</strong> pancreatic cystic lesions including intraductal papillary mucinousneoplasms in patients with end-stage renal disease on hemodialysis. Pancreas 2009; 38: 175-9.599. Wargo JA, Fernandez-del-Castillo C, Warshaw AL. Management <strong>of</strong> pancreatic serouscystadenomas. Adv Surg 2009; 43: 23-34.600. Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A. Pancreatic cyst fluid proteinexpression pr<strong>of</strong>iling for discriminating between serous cystadenoma and intraductal papillarymucinous neoplasm. Ann Surg 2009; 250: 754-60.601. Agarwal N, Kumar S, Dass J, Arora VK, Rathi V. Diffuse pancreatic serous cystadenomaassociated with neuroendocrine carcinoma: a case report and <strong>review</strong> <strong>of</strong> <strong>literature</strong>. JOP 2009; 10: 55-8.602. Marsh WL, Colonna J, Yearsley M, Bloomston M, Frankel WL. Calponin is expressed in serouscystadenomas <strong>of</strong> the pancreas but not in adenocarcinomas or endocrine tumors. ApplImmunohistochem Mol Morphol 2009; 17: 216-9.603. Akiyama T, Sadahira Y, Irei I, Nishimura H, Hida AI, Notohara K, Hamazaki S. Pancreatic serousmicrocystic adenoma with extensive oncocytic change. Pathol Int 2009; 59: 102-6.604. Hisa T, Ohkubo H, Shiozawa S, Ishigame H, Ueda M, Takamatsu M, Furutake M. Mucinouscystadenoma <strong>of</strong> the pancreas with huge mural hematoma. Pathol Int 2009; 59: 762-5.